Allos Therapeutics (ALTH) To Present Five Abstracts of FOLOTYN Data on Blood Cancers at 52nd ASH Annual Meeting
Tweet Send to a Friend
Allos Therapeutics, Inc. (Nasdaq: ALTH) announced that they will be presenting five abstracts describing FOLOTYN's effect on different types of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
